IMPACT BIOMEDICAL INC. Annual Operating Income (Loss) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Impact Biomedical Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • Impact Biomedical Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$626K, a 37.9% increase year-over-year.
  • Impact Biomedical Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$3.61M.
  • Impact Biomedical Inc. annual Operating Income (Loss) for 2023 was -$4.03M, a 18.3% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.03M -$624K -18.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$3.4M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.